BACKGROUND: Orthotopic liver transplantation (OLT) in a well-selected population is a highly successful procedure, with one-year survival rates reported to be as high as 90%. Advanced age is considered to be a contraindication. Survival rates in patients >60 years of age appear to be comparable with those of younger patients. However, little objective data exist on the outcomes of patients >65 years of age undergoing OLT. OBJECTIVE: To review the outcomes of OLT in the Irish National Transplant Unit in patients >65 years of age and to compare outcomes with patients ≤65 years of age. Second, to identify any factors that may provide valuable prognostic information regarding outcomes. METHOD: Patients >65 years of age who underwent OLT since the inception of the National Liver Unit in 1993 were identified from a prospectively maintained database. Medical records were reviewed. Survival was compared with the overall cohort using the Kaplan-Meier technique. Independent variables between the two groups were assessed using logistic regression analysis. RESULTS: Between January 1993 and December 2009, 551 patients underwent 639 transplants in the Irish National Liver Transplant Unit. Forty-three transplants were performed in 40 patients >65 years of age. Unadjusted one- and three-year survival rates for the elderly cohort were 77.8% and 64.5%, respectively. This compared with 93% and 85%, respectively, in the unselected cohort. Using Kaplan-Meier analysis, a significant benefit in survival was observed in patients ≤65 years of age (P=0.017). Similarly, when adjusted for sex, a significant difference was noted between the groups. Male patients >65 years of age had poorer survival compared with their female counterparts >65 years of age and all patients ≤65 years of age (P=0.02). There was no significant difference between the groups with respect to preoperative variables such as bilirubin, creatinine and sodium levels, and Model for End-stage Liver Disease score. A significant difference was seen in male patients >65 years of age with more than one comorbidity, compared with female patients and male patients ≤65 years of age. CONCLUSION: Male sex was associated with poorer survival in patients >65 years of age undergoing OLT. Multiple comorbidities in elderly male patients should be considered a relative contraindication in patients being assessed for OLT.
BACKGROUND: Orthotopic liver transplantation (OLT) in a well-selected population is a highly successful procedure, with one-year survival rates reported to be as high as 90%. Advanced age is considered to be a contraindication. Survival rates in patients >60 years of age appear to be comparable with those of younger patients. However, little objective data exist on the outcomes of patients >65 years of age undergoing OLT. OBJECTIVE: To review the outcomes of OLT in the Irish National Transplant Unit in patients >65 years of age and to compare outcomes with patients ≤65 years of age. Second, to identify any factors that may provide valuable prognostic information regarding outcomes. METHOD:Patients >65 years of age who underwent OLT since the inception of the National Liver Unit in 1993 were identified from a prospectively maintained database. Medical records were reviewed. Survival was compared with the overall cohort using the Kaplan-Meier technique. Independent variables between the two groups were assessed using logistic regression analysis. RESULTS: Between January 1993 and December 2009, 551 patients underwent 639 transplants in the Irish National Liver Transplant Unit. Forty-three transplants were performed in 40 patients >65 years of age. Unadjusted one- and three-year survival rates for the elderly cohort were 77.8% and 64.5%, respectively. This compared with 93% and 85%, respectively, in the unselected cohort. Using Kaplan-Meier analysis, a significant benefit in survival was observed in patients ≤65 years of age (P=0.017). Similarly, when adjusted for sex, a significant difference was noted between the groups. Male patients >65 years of age had poorer survival compared with their female counterparts >65 years of age and all patients ≤65 years of age (P=0.02). There was no significant difference between the groups with respect to preoperative variables such as bilirubin, creatinine and sodium levels, and Model for End-stage Liver Disease score. A significant difference was seen in male patients >65 years of age with more than one comorbidity, compared with female patients and male patients ≤65 years of age. CONCLUSION: Male sex was associated with poorer survival in patients >65 years of age undergoing OLT. Multiple comorbidities in elderly male patients should be considered a relative contraindication in patients being assessed for OLT.
Authors: M F Levy; P S Somasundar; L W Jennings; G J Jung; E P Molmenti; C G Fasola; R M Goldstein; T A Gonwa; G B Klintmalm Journal: Ann Surg Date: 2001-01 Impact factor: 12.969
Authors: E Prakoso; D Verran; P Dilworth; G Kyd; P Tang; C Tse; D J Koorey; S I Strasser; M Stormon; A Shun; G Thomas; D Joseph; H Pleass; J Gallagher; R Allen; M Crawford; G W McCaughan; N A Shackel Journal: Intern Med J Date: 2010-09 Impact factor: 2.048
Authors: B H Collins; J D Pirsch; Y T Becker; M J Hanaway; W J Van der Werf; A M D'Alessandro; S J Knechtle; J S Odorico; G Leverson; A Musat; M Armbrust; B N Becker; H W Sollinger; M Kalayoglu Journal: Transplantation Date: 2000-09-15 Impact factor: 4.939
Authors: Javier F Aduen; Bangarulingam Sujay; Rolland C Dickson; Michael G Heckman; Winston R Hewitt; Wolf H Stapelfeldt; Jeffrey L Steers; Denise M Harnois; David J Kramer Journal: Mayo Clin Proc Date: 2009-11 Impact factor: 7.616
Authors: M Audet; T Piardi; F Panaro; M Cag; E Ghislotti; H Habibeh; S M Giulini; D Jaeck; P h Wolf Journal: Clin Transplant Date: 2009-02-17 Impact factor: 2.863
Authors: Timothy J S Cross; Charalambos G Antoniades; Paolo Muiesan; Thawab Al-Chalabi; Varuna Aluvihare; Kosh Agarwal; Bernard C Portmann; Mohammed Rela; Nigel D Heaton; John G O'Grady; Michael A Heneghan Journal: Liver Transpl Date: 2007-10 Impact factor: 5.799
Authors: G L Adani; U Baccarani; D Lorenzin; A Rossetto; D Nicolini; A Vecchi; S De Luca; A Risaliti; D De Anna; F Bresadola; V Bresadola Journal: Transplant Proc Date: 2009-05 Impact factor: 1.066
Authors: Ju Yeon Park; Yoon Ji Choi; Hyun-Su Ri; Jung Min Lee; Hyo Jung Son; Yoon Sook Lee; Je Ho Ryu; Kwang Ho Yang Journal: Braz J Anesthesiol Date: 2021-03-21